Subject (90)bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung
Preheader (150)News ReleasebioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® LungSales of CyPath® Lung tests continue to accelera
TypographyColorsText AnalysisBody Words2048
Subject Words13
Body Emojis33
Subject Emojis1
Media AnalysisText Links15
Image Links3
Total Links18
Images5
Technical MetricsPerformancePixel Length, px3284 px
X-Spam Score0.0
Preheader OptimizedNo
TimingDay of WeekWednesday
TimeOvernight